Comparison of Endobronchial Ultrasound and/or Endoesophageal Ultrasound with Transcervical Extended Mediastinal Lymphadenectomy for Staging and Restaging.

Slides:



Advertisements
Similar presentations
Su K. Metcalfe, MD, MPH, Michael T
Advertisements

Comparison of Endobronchial Ultrasound and/or Endoesophageal Ultrasound with Transcervical Extended Mediastinal Lymphadenectomy for Staging and Restaging.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
SC17.02 Lung Cancer in China: Challenges and Perspectives
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,
Endobronchial ultrasonography (EBUS)—Its role in staging of non–small cell lung cancer and who should do it?  Rafael S. Andrade, MD, David D. Odell, MD,
Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging.
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,
Diagnostic Performance of Integrated Positron Emission Tomography/Computed Tomography for Mediastinal Lymph Node Staging in Non-small Cell Lung Cancer:
Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma
Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR  Eamon M. Berge, MD, Dara L. Aisner, MD, PhD, Robert C. Doebele,
MET-Mutated NSCLC with Major Response to Crizotinib
The True False Negative Rates of Esophageal and Endobronchial Ultrasound in the Staging of Mediastinal Lymph Nodes in Patients With Non-Small Cell Lung.
Endoscopic ultrasound-guided fine needle aspiration and endobronchial ultrasound- guided transbronchial needle aspiration: Are two better than one in mediastinal.
Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer 
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
The Efficacy of Restaging Endobronchial Ultrasound in Patients With Non-Small Cell Lung Cancer After Preoperative Therapy  Basil S. Nasir, MBBCh, Ayesha.
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
Esophageal Ultrasound-Controlled Fine Needle Aspiration for Staging of Mediastinal Lymph Nodes in Patients with Resectable Lung Cancer: Do We Always See.
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Good Vibrations and the Power of Positron Thinking: Positron Emission Tomography and Endoscopic Ultrasound in Staging of Mesothelioma—Two Case Reports 
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients with Non-small Cell Lung Cancer in Nonoperable Patients.
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature  Caicun Zhou, MD, PhD, Luan Di Yao, MD 
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy  Naomi E. Verstegen,
Clinicopathological Characteristics of Screen-Detected Lung Cancers
Non–Small-Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment  Gerald S. Falchook, MD,
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer  Allison Ackerman, MD, Michael A. Goldstein,
S768I Mutation in EGFR in Patients with Lung Cancer
Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy  Yelena.
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer  Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,
A Systematic Review of Restaging After Induction Therapy for Stage IIIa Lung Cancer: Prediction of Pathologic Stage  Sara de Cabanyes Candela, MD, Frank.
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?  Daniel J. Tandberg,
Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non–Small-Cell Lung Cancer  Sang-Won Um, MD, PhD, Hong Kwan Kim, MD,
Nicholas W. Choong, MD, Robert S. Hellman, MD 
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local.
Antiangiogenesis Induced Tumor Cavitation in Lung Cancer
Genetic Changes in Squamous Cell Lung Cancer: A Review
Transesophageal Ultrasound-Guided Fine-Needle Aspiration for the Mediastinal Restaging of Non-small Cell Lung Cancer  Martin B. von Bartheld, MSc, Michel.
Roger Hakimian, MD, Hongbin Fang, PhD, Leno Thomas, MD, Martin J
Metastatic Lung Cancer to the Pancreas
S-1 Treatment for Chemorefractory Thymic Carcinoma
EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes—an International Multi-Centre Experience  Robert C. Rintoul, FRCP, PhD, Kurt.
Walter J. Scott, MD, James Shepherd, MS, Sanjiv Sam Gambhir, MD, PhD 
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Bronchoesophageal Fistula in a Patient With Stage IIIB Non–Small-Cell Lung Cancer  Grzegorz Korpanty, MD, PhD, Scheryll Alken, MD, Lillian Smyth, MD, John.
Mark I. Block, MD  The Annals of Thoracic Surgery 
Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy  Matthew S. Block, MD, PhD, Robert Vassallo,
Super Scan Using Positron Emission Tomography in Lung Cancer Patients
Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D
Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States  Megan E. Daly, MD, Julian R.
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
A Review of First-Line Treatment for Small-cell Lung Cancer
Sebastien Gilbert, MD, David O. Wilson, MD, MPH, Neil A
Presentation transcript:

Comparison of Endobronchial Ultrasound and/or Endoesophageal Ultrasound with Transcervical Extended Mediastinal Lymphadenectomy for Staging and Restaging of Non–Small-Cell Lung Cancer  Marcin Zielinski, MD, PhD, Artur Szlubowski, MD, PhD, Marcin Kołodziej, MD, Stanislaw Orzechowski, MD, Ewa Laczynska, MD, Juliusz Pankowski, MD, PhD, Magdalena Jakubiak, BS, Anna Obrochta, BS  Journal of Thoracic Oncology  Volume 8, Issue 5, Pages 630-636 (May 2013) DOI: 10.1097/JTO.0b013e318287c0ce Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Primary staging of patients with NSCLC. CT, computed tomography; EBUS, endobronchial ultrasound; EUS, endoesophageal ultrasound; PET, positron emission tomography; TEMLA, transcervical extended mediastinal lymphadenectomy. Journal of Thoracic Oncology 2013 8, 630-636DOI: (10.1097/JTO.0b013e318287c0ce) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Restaging of NSCLC after neoadjuvant treatment. NSCLC, non–small-cell lung cancer. EBUS, endobronchial ultrasound; EUS, endoesophageal ultrasound; CUS, combined ultrasound; TEMLA, transcervical extended mediastinal lymphadenectomy; PTS, patients. Journal of Thoracic Oncology 2013 8, 630-636DOI: (10.1097/JTO.0b013e318287c0ce) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Institutional staging and restaging algorithm for NSCLC. EBUS, endobronchial ultrasound; EUS, endoesophageal ultrasound; CUS, combined ultrasound; TEMLA, transcervical extended mediastinal lymphadenectomy; PTS, patients. Journal of Thoracic Oncology 2013 8, 630-636DOI: (10.1097/JTO.0b013e318287c0ce) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions